Oric Pharmaceuticals, Inc. ORIC Q1 2026 earnings
Reported May 4, 2026 · Before market open
EPS-$0.34Miss by $0.03
EPS estimate-$0.31
Next report
Aug 11, 2026 (In 1 week)EPS estimate-$0.36
Financials
Q1 2026Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment Oric Pharmaceuticals, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI

Claude
Questions, answered.
- When did Oric Pharmaceuticals, Inc. report Q1 2026 earnings?
- Oric Pharmaceuticals, Inc. (ORIC) reported Q1 2026 earnings on May 4, 2026 before market open.
- What were Oric Pharmaceuticals, Inc.'s Q1 2026 revenue and EPS?
- Oric Pharmaceuticals, Inc. reported eps of $-0.34 for Q1 2026.
- Did Oric Pharmaceuticals, Inc. beat estimates in Q1 2026?
- EPS missed the consensus estimate of $-0.31 by $0.03.
- How did Oric Pharmaceuticals, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 19.0% from $-0.42.
- Where can I find Oric Pharmaceuticals, Inc.'s Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-203993) and the 10-Q periodic report (0001193125-26-204047) directly on SEC EDGAR. The filing index links above go to sec.gov.